Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4 / Azab M;Benchaboune M;Blinder KJ;Bressler NM;Bressler SB;Gragoudas ES;Fish GE;Hao Y;Haynes L;Lim JI;Menchini U;Miller JW;Mones J;Potter MJ;Reaves A;Rosenfeld PJ;Strong A;Su XY;Slakter JS;Schmidt-Erfurth U;Sorenson JA;Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group;Verteporfin in Photodynamic Therapy (VIP) Study Group. - In: RETINA. - ISSN 0275-004X. - ELETTRONICO. - 24:(2004), pp. 1-12.
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
MENCHINI, UGO;
2004
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
